Worse facial function outcomes for patients with Lyme disease-associated facial palsy
MONDAY, Sept. 12, 2016 (HealthDay News) — For patients with Lyme disease-associated facial palsy (LDFP), corticosteroid use is associated with worse long-term facial function outcome, according to a study published online Sept. 6 in The Laryngoscope.
Nate Jowett, M.D., from Massachusetts Eye and Ear and Harvard Medical School in Boston, and colleagues conducted a retrospective cohort study involving all patients with a prior diagnosis of unilateral LDFP who presented between 2002 and 2015. Static, dynamic, and synkinesis parameters of facial functions were graded by two blinded experts for 51 patients.
The researchers found that patients who received dual therapy with antibiotics and corticosteroids and triple therapy with antibiotics, corticosteroids, and antivirals had significantly worse facial outcomes than those who received antibiotic monotherapy; this was most pronounced among those who were assessed 12 months or later following LDFP onset.
“An association between corticosteroid use in acute LDFP and worse long-term facial function outcomes has been demonstrated,” the authors write. “Care should be taken in differentiating viral or idiopathic facial palsy (e.g., Bell palsy) from LDFP.”
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment 
Mortality, Comorbidity Risk Increased With Generalized Pustular Psoriasis 
Dexamethasone Eye Drops Can Reduce Progression to ROP Requiring Treatment 
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis 
Lower Dietary Diversity in First Year Linked to Atopic Dermatitis 
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants 
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis 
Review Shows Antihistamines Offer No Meaningful Benefit in Atopic Dermatitis 
